Pawan Karanam

Dr. Pawan Karanam is an Adjunct Assistant Professor affiliated with the Yale School of Medicine, specifically within the Department of Medical Oncology and Hematology. He completed his MD at Osmania Medical College in 1990, followed by residency in Internal Medicine at St. Vincent's Medical Center and a Hematology/Oncology fellowship at Gundersen Health System. His clinical and research focus centers on oncology, with active participation in multiple phase II and III clinical trials targeting cancers such as lymphoma, lung cancer, prostate cancer, and myeloma.

Education:

• MD, Osmania Medical College (1990)

Research Interests: Dr. Karanam’s work emphasizes translational research in cancer treatment, including novel drug combinations and therapeutic strategies. His current trials involve pembrolizumab/brentuximab vedotin for T-cell lymphoma, osimertinib/bevacizumab for lung cancer, and cytoreductive prostatectomy in metastatic prostate cancer. He also investigates belantamab mafodotin/elotuzumab in multiple myeloma and quadruplet therapies for myeloma management.

Clinical Trials Leadership: As a sub-investigator, he oversees studies across diverse oncological conditions, reflecting his commitment to advancing personalized and evidence-based therapies.

Awards: None explicitly listed. For further details, contact via pawan.karanam@yale.edu.